Research Article
Prevention of Huntington’s Disease-Like Behavioral Deficits in R6/1 Mouse by Tolfenamic Acid Is Associated with Decreases in Mutant Huntingtin and Oxidative Stress
Figure 5
Effect of tolfenamic acid treatment on the expression of mutant huntingtin (Htt) and Sp1 in the striatum. Both doses of tolfenamic acid (25 or 50 mg/kg) significantly decreased the expression of mHtt and Sp1 (a) and decreased the intensity and positive area of the EM48-positive cell (b) in the striatum. All results are expressed as . WB, ; immunohistochemistry, , . and vs. model.
(a) |
(b) |